-
甲状腺原发性滤泡性淋巴瘤(primary follicular lymphoma, PFL)是一种罕见的甲状腺恶性肿瘤,属于非霍奇金淋巴瘤(non-hodgkin's lymphoma, NHL),在我国约占NHL的8.1%~23.5%,其治疗方案及预后与肿瘤分级有关,部分甲状腺PFL可能会向侵袭性淋巴瘤转换[1]。甲状腺乳头状癌(papillary thyroid cancer, PTC)是最常见的甲状腺恶性肿瘤,其诊断及治疗方案已非常成熟。笔者报道了1例罕见的甲状腺PFL合并PTC的病例,现将该病例的诊断、治疗过程及随访结果报道如下。
甲状腺原发性滤泡性淋巴瘤合并乳头状癌1例及文献复习
Primary follicular lymphoma coexist with papillary thyroid carcinoma: a case report and literature review
-
摘要: 笔者报道了1例甲状腺原发性滤泡性淋巴瘤(PFL)合并乳头状癌(PTC)的罕见病例,该病例术前甲状腺结节细针穿刺活检诊断为淋巴瘤,但术后组织病理结果为甲状腺PFL合并PTC。笔者分析了甲状腺PFL及PTC的特点,并进行了文献复习,通过对该病例的治疗和随访观察,以期分享该类型病例影像学诊断、治疗和随访方面的有限经验。Abstract: The authors reported a rare case of primary follicular lymphoma (PFL) coexist with papillary thyroid carcinoma (PTC), the fine-needle aspiration biopsy of thyroid nodule was diagnosed with lymphoma preoperative, but the postoperative histopathological result was PFL coexist with PTC. The authors analyzed the characteristics of PFL and PTC, and carried out literature review, through the treatment and follow-up observation of this case, the authors hoped to share the limited experience in imaging diagosis, treatment and follow-up of this type of case.
-
Key words:
-
[1] 中国抗癌协会淋巴瘤专业委员会, 中华医学会血液学分会. 中国滤泡性淋巴瘤诊断与治疗指南(2020年版)[J]. 中华血液学杂志, 2020, 41(7): 537−544. DOI: 10.3760/cma.j.issn.0253-2727.2020.07.002.
Chinese Society of Lymphoma, Chinese Anti-cancer Association, Chinese Society of Hematology, Chinese Medical Association. Chinese guidelines for diagnosis and treatment of follicular lymphoma (2020)[J]. Chin J Hematol, 2020, 41(7): 537−544. DOI: 10.3760/cma.j.issn.0253-2727.2020.07.002.[2] Ali SZ, Cibas ES. The bethesda system for reporting thyroid cytopathology: definitions, criteria and explanatory notes[M]. New York: Springer, 2010: 161−165. DOI: 10.1007/978-0-387-87666-5. [3] Lan XB, Cao J, Zhu XH, et al. Concomitant papillary thyroid carcinoma and mucosa-associated lymphoid tissue thyroid lymphoma in the setting of Hashimoto thyroiditis[J/OL]. Int J Clin Exp Pathol, 2018, 11(6): 3076−3083[2022-05-17]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6958088. [4] Walsh S, Lowery AJ, Evoy D, et al. Thyroid lymphoma: recent advances in diagnosis and optimal management strategies[J]. Oncologist, 2013, 18(9): 994−1003. DOI: 10.1634/theoncologist.2013-0036. [5] Cha H, Kim JW, Suh CO, et al. Patterns of care and treatment outcomes for primary thyroid lymphoma: a single institution study[J]. Radiat Oncol J, 2013, 31(4): 177−184. DOI: 10.3857/roj.2013.31.4.177. [6] Graff-Baker A, Roman SA, Thomas DC, et al. Prognosis of primary thyroid lymphoma: demographic, clinical, and pathologic predictors of survival in 1, 408 cases[J]. Surgery, 2009, 146(6): 1105−1115. DOI: 10.1016/j.surg.2009.09.020. [7] 郑荣寿, 孙可欣, 张思维, 等. 2015年中国恶性肿瘤流行情况分析[J]. 中华肿瘤杂志, 2019, 41(1): 19−28. DOI: 10.3760/cma.j.issn.0253-3766.2019.01.005.
Zheng RS, Sun KX, Zhang SW, et al. Report of cancer epidemiology in China, 2015[J]. Chin J Oncol, 2019, 41(1): 19−28. DOI: 10.3760/cma.j.issn.0253-3766.2019.01.005.[8] Zeng HM, Chen WQ, Zheng RS, et al. Changing cancer survival in China during 2003-15: a pooled analysis of 17 population-based cancer registries[J/OL]. Lancet Glob Health, 2018, 6(5): e555−e567[2022-05-17]. https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30127-X/fulltext. DOI: 10.1016/S2214-109X(18)30127-X. [9] Pellegriti G, Frasca F, Regalbuto C, et al. Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors[J]. J Cancer Epidemiol, 2013, 2013: 965212. DOI: 10.1155/2013/965212. [10] Yao J, Li CF, Wang JJ, et al. Medullary thyroid carcinoma combined with papillary thyroid carcinoma: case report and literature review[J/OL]. Int J Clin Exp Pathol, 2020, 13(10): 2710−2717[2022-05-17]. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642704. [11] Popivanov GI, Bochev P, Hristoskova R, et al. Synchronous papillary thyroid cancer and non-Hodgkin lymphoma: case report[J]. Medicine (Baltimore), 2018, 97(6): e9831. DOI: 10.1097/MD.0000000000009831. [12] Chen L, Liu YH, Dong CH. Coexistence of primary thyroid diffuse large B cell lymphoma and papillary thyroid carcinoma: a case report and literature review[J]. J Int Med Res, 2019, 47(10): 5289−5293. DOI: 10.1177/0300060519869133.